Medication Interruptions and Subsequent Disease Flares During the COVID-19 Pandemic: A Longitudinal Online Study of Patients With Rheumatic Disease

被引:16
作者
Dharia, Tiffany [1 ]
Venkatachalam, Shilpa [2 ]
Baker, Joshua F. [1 ]
Banerjee, Shubhasree [1 ]
Curtis, David [2 ]
Danila, Maria I. [3 ]
Gavigan, Kelly [2 ]
Gordon, Jennifer [4 ]
Merkel, Peter A. [1 ]
Shaw, Dianne G. [5 ]
Young, Kalen [5 ]
Curtis, Jeffrey R. [3 ]
Nowell, William B. [2 ]
George, Michael D. [1 ]
机构
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Global Hlth Liv Fdn, Upper Nyack, New York, NY USA
[3] Univ Alabama Birmingham, Birmingham, AL USA
[4] Temple Univ, Philadelphia, PA 19122 USA
[5] Vasculitis Fdn, Kansas City, MO USA
关键词
PSORIATIC-ARTHRITIS; RISK;
D O I
10.1002/acr.24837
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective We aimed to assess trends in anxiety and interruptions in disease-modifying antirheumatic drug (DMARD) use among patients with rheumatic diseases during the COVID-19 pandemic and to evaluate whether DMARD interruptions were associated with disease flares. Methods ArthritisPower, the Vasculitis Patient-Powered Research Network, and other patient organizations invited members to join a 52-week longitudinal study, with baseline surveys completed March 29 to June 30, 2020, with follow-up through May 2021. Logistic regression incorporating generalized estimating equations evaluated associations between interruptions in DMARD use and self-reported disease flares at the next survey, adjusting for demographic characteristics, medications, disease, and calendar time. Results Among 2,424 patients completing a median of 5 follow-up surveys, the mean age was 57 years, 87% were female, and the most common conditions were rheumatoid arthritis, vasculitis, and psoriatic arthritis. Average Patient-Reported Outcomes Measurement Information System (PROMIS) anxiety T scores decreased from April 2020 (58.7) to May 2021 (53.7) (P < 0.001 for trend). Interruptions in DMARD use decreased from April (11.2%) to December 2020 (7.5%) (P < 0.001) but increased through May 2021 (14.0%) (P < 0.001). Interruptions in DMARD use were associated with a significant increase in severe flares (rated >= 6 of 10) at the next survey (12.9% versus 8.0% [odds ratio (OR) 1.71 (95% confidence interval [95% CI 1.23, 2.36]) although not any flare (OR 1.18 [95% CI 0.89, 1.58])]. Conclusion Anxiety and interruptions in DMARD use initially decreased over time, but DMARD interruptions increased during 2021, possibly related to an increase in COVID-19 cases or vaccine availability. Interruptions in DMARD use were associated with increased rates of severe disease flares, highlighting the importance of avoiding unnecessary DMARD interruptions.
引用
收藏
页码:733 / 740
页数:8
相关论文
共 27 条
[1]  
American College of Rheumatology, COVID 19 VACC CLIN G
[2]   Content and Construct Validity, Reliability, and Responsiveness of the Rheumatoid Arthritis Flare Questionnaire: OMERACT 2016 Workshop Report [J].
Bartlett, Susan J. ;
Barbic, Skye P. ;
Bykerk, Vivian P. ;
Choy, Ernest H. ;
Aiten, Rieke ;
Christensen, Robin ;
den Broeder, Alfons ;
Fautrel, Bruno ;
Furst, Daniel E. ;
Guillemin, Francis ;
Hewlett, Sarah ;
Leong, Amye L. ;
Lyddiatt, Anne ;
March, Lyn ;
Montie, Pamela ;
Pohl, Christoph ;
Voshaar, Marieke Scholte ;
Woodworth, Thasia G. ;
Bingham, Clifton O., III .
JOURNAL OF RHEUMATOLOGY, 2017, 44 (10) :1536-1543
[3]   Patient-Physician Discordance in Assessments of Global Disease Severity in Rheumatoid Arthritis [J].
Barton, Jennifer L. ;
Imboden, John ;
Graf, Jonathan ;
Glidden, David ;
Yelin, Edward H. ;
Schillinger, Dean .
ARTHRITIS CARE & RESEARCH, 2010, 62 (06) :857-864
[4]   Identifying flares in rheumatoid arthritis: reliability and construct validation of the OMERACT RA Flare Core Domain Set [J].
Bykerk, Vivian P. ;
Bingham, Clifton O. ;
Choy, Ernest H. ;
Lin, Daming ;
Alten, Rieke ;
Christensen, Robin ;
Furst, Daniel E. ;
Hewlett, Sarah ;
Leong, Amye ;
March, Lyn ;
Woodworth, Thasia ;
Boire, Gilles ;
Haraoui, Boulos ;
Hitchon, Carol ;
Jamal, Shahin ;
Keystone, Edward C. ;
Pope, Janet ;
Tin, Diane ;
Thorne, J. Carter ;
Bartlett, Susan J. .
RMD OPEN, 2016, 2 (01)
[5]   American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 1 [J].
Curtis, Jeffrey R. ;
Johnson, Sindhu R. ;
Anthony, Donald D. ;
Arasaratnam, Reuben J. ;
Baden, Lindsey R. ;
Bass, Anne R. ;
Calabrese, Cassandra ;
Gravallese, Ellen M. ;
Harpaz, Rafael ;
Sadun, Rebecca E. ;
Turner, Amy S. ;
Williams, Eleanor Anderson ;
Mikuls, Ted R. .
ARTHRITIS & RHEUMATOLOGY, 2021, 73 (07) :1093-1107
[6]   Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies [J].
Danza, A. ;
Ruiz-Irastorza, G. .
LUPUS, 2013, 22 (12) :1286-1294
[7]   Risk of COVID-19 in Rheumatoid Arthritis: A National Veterans Affairs Matched Cohort Study in At-Risk Individuals [J].
England, Bryant R. ;
Roul, Punyasha ;
Yang, Yangyuna ;
Kalil, Andre C. ;
Michaud, Kaleb ;
Thiele, Geoffrey M. ;
Sauer, Brian C. ;
Baker, Joshua F. ;
Mikuls, Ted R. .
ARTHRITIS & RHEUMATOLOGY, 2021, 73 (12) :2179-2188
[8]   Disruptions in Rheumatology Care and the Rise of Telehealth in Response to the COVID-19 Pandemic in a Community Practice-Based Network [J].
George, Michael D. ;
Danila, Maria, I ;
Watrous, Daniel ;
Reddy, Shanmugapriya ;
Alper, Jeffrey ;
Xie, Fenglong ;
Nowell, W. Benjamin ;
Kallich, Joel ;
Clinton, Cassie ;
Saag, Kenneth G. ;
Curtis, Jeffrey R. .
ARTHRITIS CARE & RESEARCH, 2021, 73 (08) :1153-1161
[9]   Social Distancing, Health Care Disruptions, Telemedicine Use, and Treatment Interruption During the COVID-19 Pandemic in Patients With or Without Autoimmune Rheumatic Disease [J].
George, Michael D. ;
Baker, Joshua F. ;
Banerjee, Shubhasree ;
Busch, Howard ;
Curtis, David ;
Danila, Maria I. ;
Gavigan, Kelly ;
Kirby, Daniel ;
Merkel, Peter A. ;
Munoz, George ;
Nowell, William Benjamin ;
Stewart, Patrick ;
Sunshine, William ;
Venkatachalam, Shilpa ;
Xie, Fenglong ;
Curtis, Jeffrey R. .
ACR OPEN RHEUMATOLOGY, 2021, 3 (06) :381-389
[10]   Concerns, Healthcare Use, and Treatment Interruptions in Patients With Common Autoimmune Rheumatic Diseases During the COVID-19 Pandemic [J].
George, Michael D. ;
Venkatachalam, Shilpa ;
Banerjee, Shubhasree ;
Baker, Joshua F. ;
Merkel, Peter A. ;
Gavigan, Kelly ;
Curtis, David ;
Danila, Maria, I ;
Curtis, Jeffrey R. ;
Nowell, W. Benjamin .
JOURNAL OF RHEUMATOLOGY, 2021, 48 (04) :603-607